Biovica International AB (publ) (STO:BIOVIC.B)
Sweden · Delayed Price · Currency is SEK 0.5280
+0.0380 (7.76%)
Jul 24, 2026, 5:29 PM CET
Biovica International AB Market Cap
Biovica International AB has a market cap or net worth of 143.04 million as of July 24, 2026. Its market cap has increased by 125.73% in one year.
Market Cap
143.04M
Enterprise Value
76.92M
Revenue
13.49M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.53
ChartMarket Cap Chart
Since March 29, 2017, Biovica International AB's market cap has decreased from 210.00M to 143.04M, a decrease of -31.89%. That is a compound annual growth rate of -4.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 143.04M | 32.43% |
| Dec 30, 2025 | 108.01M | -44.77% |
| Dec 30, 2024 | 195.57M | -9.82% |
| Dec 29, 2023 | 216.86M | -41.83% |
| Dec 30, 2022 | 372.79M | -68.37% |
| Dec 30, 2021 | 1.18B | -18.58% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Simris Group AB (PUBL) | 182.22M |
| Elicera Therapeutics AB | 175.52M |
| Initiator Pharma | 167.03M |
| Xintela AB | 162.78M |
| Diamyd Medical AB | 162.42M |
| Nanologica AB | 144.00M |
| Active Biotech AB | 142.35M |
| Alzinova AB | 141.44M |